Literature DB >> 26698157

Outcome of paroxysmal atrial fibrillation ablation with the cryoballoon using two different application times: the 4- versus 3-min protocol.

Florian Straube1, Uwe Dorwarth2, Stefan Hartl2, Benedikt Bunz2, Michael Wankerl2, Ullrich Ebersberger2, Ellen Hoffmann2.   

Abstract

PURPOSE: The second-generation cryoballoon (CBG2) is highly effective for pulmonary vein isolation (PVI) in paroxysmal atrial fibrillation (PAF). One-year outcome data are consistent among different research groups. First results suggest that a shortened application time might be equally effective. The objective of the study was to compare procedural and outcome data for a 240 and 180-s protocol.
METHODS: Prospectively, consecutive patients with symptomatic PAF underwent initial PVI with CBG2. In succession, two groups were created: the application time was 240 s in group 1 and 180 s in group 2. In both groups, a bonus application was applied. Periprocedural data, complications, and freedom from atrial fibrillation (AF)/AT/symptoms were compared between the groups.
RESULTS: From May 2012 to June 2013, 114 patients (57 per group, 38% female) were included. The mean left atrial dwelling time decreased by 19 min (-16%) in group 2 compared to group 1 (p = 0.005). Intraprocedural pulmonary vein (PV) reconduction occurred infrequently (0.4% in both groups, p = 1.0). One persistent PNP occurred and resolved during the follow-up. Complications were without significant differences. One patient was lost to follow-up. The cumulative rates of freedom from recurrence at 12 months are 76.8% in group 1 and 83.6% in group 2. After a mean follow-up of 491 ± 208 days, the rates of freedom from AF/AT/symptoms at last visit were 38/57 (67%) and 44/56 (78.6%) in groups 1 and 2 (p = 0.14), respectively. Female sex was identified as a predictor for recurrence.
CONCLUSIONS: Compared to a protocol with cryoballoon applications of 240 s, a shortened application time to 180 s results in a faster procedure with comparable high rates of freedom from AF at 16 months. Female sex seems to be predictive for recurrences; this finding has to be reconfirmed in a larger population.

Entities:  

Keywords:  Ablation; Application time; Atrial fibrillation; Cryoballoon; Dosing

Mesh:

Year:  2015        PMID: 26698157     DOI: 10.1007/s10840-015-0084-3

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  37 in total

1.  Histological findings induced by different energy sources in experimental atrial ablation in sheep.

Authors:  Heike Aupperle; Nicolas Doll; Thomas Walther; Cris Ullmann; Heinz-Adolf Schoon; Friedrich Wilhelm Mohr
Journal:  Interact Cardiovasc Thorac Surg       Date:  2005-07-11

2.  The incidence of phrenic nerve injury during pulmonary vein isolation using the second-generation 28 mm cryoballoon.

Authors:  Andreas Metzner; Peter Rausch; Christine Lemes; Bruno Reissmann; Alexander Bardyszewski; Roland Tilz; Andreas Rillig; Shibu Mathew; Sebastian Deiss; Masashi Kamioka; Tobias Toennis; Tina Lin; Feifan Ouyang; Karl-Heinz Kuck; Erik Wissner
Journal:  J Cardiovasc Electrophysiol       Date:  2014-01-30

3.  Safety and efficacy of a second-generation cryoballoon in the ablation of paroxysmal atrial fibrillation.

Authors:  Raphaël P Martins; David Hamon; Olivier Césari; Albin Behaghel; Nathalie Behar; Jean-Marc Sellal; Jean-Claude Daubert; Philippe Mabo; Dominique Pavin
Journal:  Heart Rhythm       Date:  2014-01-01       Impact factor: 6.343

4.  Cryoballoon ablation of paroxysmal atrial fibrillation: 5-year outcome after single procedure and predictors of success.

Authors:  Thomas Neumann; Maciej Wójcik; Alexander Berkowitsch; Damir Erkapic; Sergey Zaltsberg; Harald Greiss; Dimitri Pajitnev; Stefan Lehinant; Jörn Schmitt; Christian W Hamm; Heinz F Pitschner; Malte Kuniss
Journal:  Europace       Date:  2013-02-17       Impact factor: 5.214

5.  Increased incidence of esophageal thermal lesions using the second-generation 28-mm cryoballoon.

Authors:  Andreas Metzner; Andre Burchard; Peter Wohlmuth; Peter Rausch; Alexander Bardyszewski; Christina Gienapp; Roland Richard Tilz; Andreas Rillig; Shibu Mathew; Sebastian Deiss; Hisaki Makimoto; Feifan Ouyang; Karl-Heinz Kuck; Erik Wissner
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-06-07

6.  Two versus one repeat freeze-thaw cycle(s) after cryoballoon pulmonary vein isolation: the alster extra pilot study.

Authors:  Kyoung Ryul Julian Chun; Alexander Fürnkranz; Ilka Köster; Andreas Metzner; Tobias Tönnis; Peter Wohlmuth; Erik Wissner; Boris Schmidt; Feifan Ouyang; Karl Heinz Kuck
Journal:  J Cardiovasc Electrophysiol       Date:  2012-04-04

Review 7.  Experimental cryosurgery investigations in vivo.

Authors:  A A Gage; J M Baust; J G Baust
Journal:  Cryobiology       Date:  2009-10-13       Impact factor: 2.487

8.  Durability of Pulmonary Vein Isolation with Cryoballoon Ablation: Results from the Sustained PV Isolation with Arctic Front Advance (SUPIR) Study.

Authors:  Vivek Y Reddy; Lucie Sediva; Jan Petru; Jan Skoda; Milan Chovanec; Zita Chitovova; Paola Di Stefano; Ethel Rubin; Srinivas Dukkipati; Petr Neuzil
Journal:  J Cardiovasc Electrophysiol       Date:  2015-04-15

9.  Improved procedural efficacy of pulmonary vein isolation using the novel second-generation cryoballoon.

Authors:  Alexander Fürnkranz; Stefano Bordignon; Boris Schmidt; Melanie Gunawardene; Britta Schulte-Hahn; Verena Urban; Frank Bode; Bernd Nowak; Julian K R Chun
Journal:  J Cardiovasc Electrophysiol       Date:  2013-02-11

10.  Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial.

Authors:  Douglas L Packer; Robert C Kowal; Kevin R Wheelan; James M Irwin; Jean Champagne; Peter G Guerra; Marc Dubuc; Vivek Reddy; Linda Nelson; Richard G Holcomb; John W Lehmann; Jeremy N Ruskin
Journal:  J Am Coll Cardiol       Date:  2013-03-21       Impact factor: 24.094

View more
  10 in total

1.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  Heart Rhythm       Date:  2017-05-12       Impact factor: 6.343

2.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; José Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  Heart Rhythm       Date:  2012-03-01       Impact factor: 6.343

Review 3.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Gerhard Hindricks; Riccardo Cappato; Young-Hoon Kim; Eduardo B Saad; Luis Aguinaga; Joseph G Akar; Vinay Badhwar; Josep Brugada; John Camm; Peng-Sheng Chen; Shih-Ann Chen; Mina K Chung; Jens Cosedis Nielsen; Anne B Curtis; D Wyn Davies; John D Day; André d'Avila; N M S Natasja de Groot; Luigi Di Biase; Mattias Duytschaever; James R Edgerton; Kenneth A Ellenbogen; Patrick T Ellinor; Sabine Ernst; Guilherme Fenelon; Edward P Gerstenfeld; David E Haines; Michel Haissaguerre; Robert H Helm; Elaine Hylek; Warren M Jackman; Jose Jalife; Jonathan M Kalman; Josef Kautzner; Hans Kottkamp; Karl Heinz Kuck; Koichiro Kumagai; Richard Lee; Thorsten Lewalter; Bruce D Lindsay; Laurent Macle; Moussa Mansour; Francis E Marchlinski; Gregory F Michaud; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Ken Okumura; Douglas Packer; Evgeny Pokushalov; Matthew R Reynolds; Prashanthan Sanders; Mauricio Scanavacca; Richard Schilling; Claudio Tondo; Hsuan-Ming Tsao; Atul Verma; David J Wilber; Teiichi Yamane
Journal:  Europace       Date:  2018-01-01       Impact factor: 5.214

Review 4.  The Impact of Advances in Atrial Fibrillation Ablation Devices on the Incidence and Prevention of Complications.

Authors:  Fehmi Keçe; Katja Zeppenfeld; Serge A Trines
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-08

5.  Radiofrequency catheter ablation for redo procedures after pulmonary vein isolation with the cryoballoon technique : Long-term outcome.

Authors:  Klaus Kettering; Felix Gramley
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2017-02-27

6.  Comparative Study of Cryoballoon versus Radiofrequency for Pulmonary Vein Isolation when Combined with vein of Marshall Ethanol Infusion for Paroxysmal Atrial Fibrillation.

Authors:  Kaoru Okishige; Naohiko Kawaguchi; Shinsuke Iwai; Yasuteru Yamauchi; Takehiko Keida; Tetsuo Sasano; Kenzo Hirao; Miguel Valderrabano
Journal:  J Atr Fibrillation       Date:  2020-02-28

7.  Individualized or fixed approach to pulmonary vein isolation utilizing the fourth-generation cryoballoon in patients with paroxysmal atrial fibrillation: the randomized INDI-FREEZE trial.

Authors:  Christian Hendrik Heeger; Sorin Stefan Popescu; Roza Saraei; Bettina Kirstein; Sascha Hatahet; Omar Samara; Anna Traub; Marcel Fehe; Gabriele D'Ambrosio; Ahmad Keelani; Michael Schlüter; Charlotte Eitel; Julia Vogler; Karl Heinz Kuck; Roland Richard Tilz
Journal:  Europace       Date:  2022-07-15       Impact factor: 5.486

8.  Bonus-freeze: benefit or risk? Two-year outcome and procedural comparison of a "bonus-freeze" and "no bonus-freeze" protocol using the second-generation cryoballoon for pulmonary vein isolation.

Authors:  Christian-H Heeger; Erik Wissner; Peter Wohlmuth; Shibu Mathew; Kentaro Hayashi; Christian Sohns; Bruno Reißmann; Christine Lemes; Tilman Maurer; Ardan M Saguner; Francesco Santoro; Johannes Riedl; Feifan Ouyang; Karl-Heinz Kuck; Andreas Metzner
Journal:  Clin Res Cardiol       Date:  2016-04-16       Impact factor: 5.460

Review 9.  Strategies to Improve the Outcome of Cryoballoon Ablation in the Treatment of Atrial Fibrillation.

Authors:  Ying Huang; Yuehan Wang; Chenyu Song
Journal:  Biomed Res Int       Date:  2020-04-06       Impact factor: 3.411

10.  Relationship between time-to-isolation and freeze duration: Computational modeling of dosing for Arctic Front Advance and Arctic Front Advance Pro cryoballoons.

Authors:  Michael K Getman; Erik Wissner; Ravi Ranjan; Jean-Pierre Lalonde
Journal:  J Cardiovasc Electrophysiol       Date:  2019-09-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.